4//SEC Filing
Dermetzis Petros 4
Accession 0001327811-19-000204
CIK 0001327811other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 8:33 PM ET
Size
17.4 KB
Accession
0001327811-19-000204
Insider Transaction Report
Form 4
Workday, Inc.WDAY
Dermetzis Petros
Chief Products Officer
Transactions
- Sale
Class A Common Stock
2019-12-05$164.64/sh−200$32,928→ 154,365 total - Sale
Class A Common Stock
2019-12-05$160.43/sh−1,500$240,650→ 156,329 total - Sale
Class A Common Stock
2019-12-05$161.48/sh−1,264$204,105→ 155,065 total - Sale
Class A Common Stock
2019-12-05$162.24/sh−500$81,122→ 154,565 total
Holdings
- 40,000
Stock Option (right to buy)
Exercise: $7.05Exp: 2022-05-04→ Class A Common Stock (40,000 underlying) - 43,896(indirect: By Trust)
Class A Common Stock
- 25,000
Stock Option (right to buy)
Exercise: $2.30Exp: 2021-02-18→ Class A Common Stock (25,000 underlying)
Footnotes (12)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F10]All shares of Class A and Class B Common Stock will convert automatically into shares of a single class of Common Stock upon the earliest to occur of the following: (a) upon the election by the holders of a majority of the then outstanding shares of Class B Common Stock, (b) the date when the number of outstanding shares of Class B Common Stock represents less than 9% of all outstanding shares of Class A and Class B Common Stock, (c) October 11, 2032 or (d) nine (9) months after the death of the later to die of David A. Duffield and Aneel Bhusri. The shares of Class A and Class B Common Stock have no expiration date.
- [F11]Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon any transfer, whether or not for value, except for certain permitted transfers described in, and transfers to any "permitted transferee" as defined in, the Issuer's restated certificate of incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date.
- [F12]This stock option grant became fully vested on July 1, 2016.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $159.8900 to $160.8899, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- [F3]Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates.
- [F4]Includes 63 shares of Class A Common Stock that were purchased through the Issuer's Employee Stock Purchase Program.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $161.0200 to $162.0199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $162.0600 to $163.0599, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $164.2200 to $165.2199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- [F8]The shares are held in a joint revocable trust dated October 15, 1999. The trust is in the name of the Reporting Person and his spouse, who are both sole trustees and beneficiaries of the trust.
- [F9]This stock option grant became fully vested on March 3, 2018.
Documents
Issuer
Workday, Inc.
CIK 0001327811
Entity typeother
Related Parties
1- filerCIK 0001731581
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 8:33 PM ET
- Size
- 17.4 KB